We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAre capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?AuthorsBajetta, Emilio; Catena, Laura; Procopio, Giuseppe; De Dosso, Sara; Bichisao, Ettore; Ferrari, Leonardo; Martinetti, Antonia; Platania, Marco; Verzoni, Elena; Formisano, Barbara; Bajetta, RobertoAbstractThe aim of this trial was to evaluate the safety and efficacy of oxaliplatin and capecitabine (XELOX) in neuroendocrine tumours' (NETs) treatment.PublicationCancer chemotherapy and pharmacology, 2007, Vol 59, Issue 5, p637ISSN0344-5704Publication typeJournal ArticleDOI10.1007/s00280-006-0306-6